The Company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the ADSs sold in the Offering on the same terms and conditions. The terms of the ADSs to be issued in the Offering are to be determined upon pricing of the Offering. The Offering is subject to market conditions, and there can be no assurance as to whether or when the Offering may be completed or as to the actual size or terms of the Offering.    

The Company intends to use the net proceeds from the Offering for operating costs, capital expenditures and for general corporate purposes, including working capital.